Targeting protein-protein interactions by rational design: mimicry of protein surfaces

被引:134
作者
Fletcher, Steven [1 ]
Hamilton, Andrew D. [1 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
关键词
protein-protein interaction; inhibitor; proteomimetics; surface; recognition;
D O I
10.1098/rsif.2006.0115
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Protein-protein interactions play key roles in a range of biological processes, and are therefore important targets for the design of novel therapeutics. Unlike in the design of enzyme active site inhibitors, the disruption of protein-protein interactions is far more challenging, due to such factors as the large interfacial areas involved and the relatively fiat and featureless topologies of these surfaces. Nevertheless, in spite of such challenges, there has been considerable progress in recent years. In this review, we discuss this progress in the context of mimicry of protein surfaces: targeting protein-protein interactions by rational design.
引用
收藏
页码:215 / 233
页数:19
相关论文
共 110 条
[1]   CYSTEINE PAIRING IN THE GLYCOPROTEIN-IIBIIIA ANTAGONIST KISTRIN USING NMR, CHEMICAL-ANALYSIS, AND STRUCTURE CALCULATIONS [J].
ADLER, M ;
CARTER, P ;
LAZARUS, RA ;
WAGNER, G .
BIOCHEMISTRY, 1993, 32 (01) :282-289
[2]   Toll signaling pathways in the innate immune response [J].
Anderson, KV .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :13-19
[3]   Inhibition of ICAM-1/LFA-1-mediated heterotypic T-cell adhesion to epithelial cells: design of ICAM-1 cyclic peptides [J].
Anderson, ME ;
Yakovleva, T ;
Hu, YB ;
Siahaan, TJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) :1399-1402
[4]  
[Anonymous], 1998, Biochim. Biophys. Acta
[5]   Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream [J].
Arkin, MR ;
Wells, JA .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :301-317
[6]  
Aviezer D, 2000, CANCER RES, V60, P2973
[7]   Tetrabiphenylporphyrin-based receptors for protein surfaces show sub-nanomolar affinity and enhance unfolding [J].
Aya, T ;
Hamilton, AD .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) :2651-2654
[8]   A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses [J].
Bartfai, T ;
Behrens, MM ;
Gaidarova, S ;
Pemberton, J ;
Shivanyuk, A ;
Rebek, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7971-7976
[9]   Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice [J].
Blaskovich, MA ;
Lin, Q ;
Delarue, FL ;
Sun, J ;
Park, HS ;
Coppola, D ;
Hamilton, AD ;
Sebti, SM .
NATURE BIOTECHNOLOGY, 2000, 18 (10) :1065-1070
[10]   Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions [J].
Boussard, C ;
Klimkait, T ;
Mahmood, N ;
Pritchard, M ;
Gilbert, IH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) :2673-2676